Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Spinogenix, Inc. logo — Developing a new class of therapeutics for neurodegenerative...

Spinogenix, Inc.

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

Founded 2016 United States Los Angeles, United States 4 employees Total: $8.36M Biotechnology, Health Care +1

General Information

Company Name Spinogenix, Inc.
Founded Year 2016
Location United States Los Angeles, United States
Employees 4
Industries Biotechnology, Health Care, Health and Wellness
Social

BounceWatch is an independent company data service, not affiliated with Spinogenix, Inc.. To contact Spinogenix, Inc., visit spinogenix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Spinogenix, Inc. compare?

A PDF of Spinogenix, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Spinogenix, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 13, 2026

Our CEO @StellaSarraf is attending the Forbes 30/50 5-Year Anniversary Summit this week in New York.

Get alerts when Spinogenix, Inc. shows new signals

About Spinogenix, Inc.

Spinogenix, Inc. is a biotechnology startup focused on developing innovative therapeutics for neurodegenerative and psychiatric diseases. The company's mission is to address the underlying causes of cognitive and motor function declines by regenerating synapses, a unique approach in the field. Founded in 2016, Spinogenix has pioneered the development of first-in-class small molecule drugs (SPGs) that have shown promise in restoring lost synapses, offering a potential breakthrough in the treatment of conditions involving synaptic loss. The company's recent Venture - Series Unknown investment on 21 June 2024 underscores the recognition and support it has garnered within the biotechnology and health care industries. As Spinogenix continues to advance its groundbreaking science and therapeutic development, it is poised to make significant contributions to the treatment of neurodegenerative diseases.

Business keywords: Neurodegenerative diseases, Psychiatric diseases, Synaptic loss, Cognitive function, Motor function, Therapeutics development, Small molecule drugs, Central nervous system disorders, Neurorestorative therapies, Synaptic regeneration, Disease-specific degenerative processes, SPGs, Molecular target, Neuroscience research, Synaptic restoration

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $2.80M -
01 Jun 2024
Grant $3.00M 1
National Institute of Health
National Institute of Health
01 Sep 2023
Early VC $1.56M -
01 Feb 2021
Seed $900.00K -
01 May 2018
Seed $100.00K -
01 Oct 2017

Spinogenix, Inc. Alternatives & Competitors

View All Alternatives
Spinogenix, Inc. vs
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. United States

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

IPO
29 employees
Biotechnology, Health Care
Spinogenix, Inc. vs
Ophidion
Ophidion

Advancing brain-targeted therapies with precision and innovation for neurodegenerative and anxiety-r...

Convertible Note
Biotechnology, Health Care
Spinogenix, Inc. vs
Rectify Pharma
Rectify Pharma United States

Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein function fo...

Series A
20 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Spinogenix, Inc.

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases
Spinogenix, Inc. was founded in 2016.
Spinogenix, Inc. is headquartered in Los Angeles, United States.
Spinogenix, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Neurodegenerative diseases, Psychiatric diseases, Synaptic loss and Cognitive function.
Spinogenix, Inc. has approximately 4 employees.
Spinogenix, Inc. has completed 5 funding rounds, raising a total of $8.36M.
Top alternatives and competitors to Spinogenix, Inc. include Cognition Therapeutics, Inc., Ophidion, Rectify Pharma, Biosplice Therapeutics, ProJenX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Spinogenix, Inc. and Cognition Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Spinogenix, Inc., https://bouncewatch.com/company/spinogenix-inc, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes